Ingrid Jolanda M De Vries (Ingrid Jolanda M de Vries, I Jolanda de Vries, I Jolanda M de Vries, I J M de Vries)

ResearcherID Ciência ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 31

Top Venues

Nature communications

Cancers

International journal of molecular sciences

Journal for immunotherapy of cancer

Radboud university medical center

University Medical Center Utrecht (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Radboud university medical center

Netherlands

Professor Translational Tumor Immunology :: Tumor Immunology

Education History

University Medical Center Utrecht - Sep 25 1997

Netherlands

PHD

Publications

Carolina Alves Costa Silva, Gianmarco Piccinno, Déborah Suissa, Mélanie Bourgin, Ghaith Bakdash, Sylvère Durand, Roxanne Birebent, Marine Fidelle, Cissé Sow, Fanny Aprahamian, Paolo Manghi, Michal Punčochář, Francesco Asnicar, Federica Pinto, Federica Armanini, Safae Terrisse, Bertrand Routy, Damien Drubay, Alexander M M Eggermont, Guido Kroemer, Nicola Segata, Laurence Zitvogel, Lisa Derosa, Kalijn F Bol, Ingrid Jolanda M De Vries
Influence of microbiota-associated metabolic reprogramming on clinical outcome in patients with melanoma from the randomized adjuvant dendritic cell-based MIND-DC trial. Nature communications 15 (1) (2024)
Kalijn F Bol, Ghaith Bakdash, Martine Bloemendal, Wouter W van Willigen, Simone Hins-de Bree, Anna L de Goede, Annemiek J de Boer, Kevin J H Bos, Tjitske Duiveman-de Boer, Michel A M Olde Nordkamp, Tom G M van Oorschot, Carlijn J Popelier, Jeanne M Pots, Nicole M Scharenborg, Mandy W M M van de Rakt, Valeska de Ruiter, Wilmy S van Meeteren, Michelle M van Rossum, Sandra J Croockewit, Bouke J Koeneman, Jeroen H A Creemers, Inge M N Wortel, Caroline Angerer, Mareke Brüning, Katja Petry, Andrzej Dzionek, Astrid A van der Veldt, Dirk J van Grünhagen, Johanna E M Werner, Johannes J Bonenkamp, John B A G Haanen, Marye J Boers-Sonderen, Rutger H T Koornstra, Martijn F Boomsma, Erik H J Aarntzen, Martin Gotthardt, James Nagarajah, Theo J M de Witte, Carl G Figdor, Johannes H W de Wilt, Johannes C Textor, Jan Willem B de Groot, Winald R Gerritsen, Ingrid Jolanda M De Vries
Adjuvant dendritic cell therapy in stage IIIB/C melanoma: the MIND-DC randomized phase III trial. Nature communications 15 (1) (2024)
Kalijn F Bol, Ghaith Bakdash, Martine Bloemendal, Wouter W van Willigen, Simone Hins-de Bree, Anna L de Goede, Annemiek J de Boer, Kevin J H Bos, Tjitske Duiveman-de Boer, Michel A M Olde Nordkamp, Tom G M van Oorschot, Carlijn J Popelier, Jeanne M Pots, Nicole M Scharenborg, Mandy W M M van de Rakt, Valeska de Ruiter, Wilmy S van Meeteren, Michelle M van Rossum, Sandra J Croockewit, Bouke J Koeneman, Jeroen H A Creemers, Inge M N Wortel, Caroline Angerer, Mareke Brüning, Katja Petry, Andrzej Dzionek, Astrid A van der Veldt, Dirk J van Grünhagen, Johanna E M Werner, Johannes J Bonenkamp, John B A G Haanen, Marye J Boers-Sonderen, Rutger H T Koornstra, Martijn F Boomsma, Erik H J Aarntzen, Martin Gotthardt, James Nagarajah, Theo J M de Witte, Carl G Figdor, Johannes H W de Wilt, Johannes C Textor, Jan Willem B de Groot, Winald R Gerritsen, Ingrid Jolanda M De Vries
Adjuvant dendritic cell therapy in stage IIIB/C melanoma: the MIND-DC randomized phase III trial. Nature communications 15 (1) (2024)
Carolina Alves Costa Silva, Gianmarco Piccinno, Déborah Suissa, Mélanie Bourgin, Ghaith Bakdash, Sylvère Durand, Roxanne Birebent, Marine Fidelle, Cissé Sow, Fanny Aprahamian, Paolo Manghi, Michal Punčochář, Francesco Asnicar, Federica Pinto, Federica Armanini, Safae Terrisse, Bertrand Routy, Damien Drubay, Alexander M M Eggermont, Guido Kroemer, Nicola Segata, Laurence Zitvogel, Lisa Derosa, Kalijn F Bol, Ingrid Jolanda M De Vries
Influence of microbiota-associated metabolic reprogramming on clinical outcome in patients with melanoma from the randomized adjuvant dendritic cell-based MIND-DC trial. Nature communications 15 (1) (2024)
Carolina Alves Costa Silva, Gianmarco Piccinno, Déborah Suissa, Mélanie Bourgin, Ghaith Bakdash, Sylvère Durand, Roxanne Birebent, Marine Fidelle, Cissé Sow, Fanny Aprahamian, Paolo Manghi, Michal Punčochář, Francesco Asnicar, Federica Pinto, Federica Armanini, Safae Terrisse, Bertrand Routy, Damien Drubay, Alexander M M Eggermont, Guido Kroemer, Nicola Segata, Laurence Zitvogel, Lisa Derosa, Kalijn F Bol, Ingrid Jolanda M De Vries
Influence of microbiota-associated metabolic reprogramming on clinical outcome in patients with melanoma from the randomized adjuvant dendritic cell-based MIND-DC trial. Nature communications 15 (1) (2024)
Kalijn F Bol, Ghaith Bakdash, Martine Bloemendal, Wouter W van Willigen, Simone Hins-de Bree, Anna L de Goede, Annemiek J de Boer, Kevin J H Bos, Tjitske Duiveman-de Boer, Michel A M Olde Nordkamp, Tom G M van Oorschot, Carlijn J Popelier, Jeanne M Pots, Nicole M Scharenborg, Mandy W M M van de Rakt, Valeska de Ruiter, Wilmy S van Meeteren, Michelle M van Rossum, Sandra J Croockewit, Bouke J Koeneman, Jeroen H A Creemers, Inge M N Wortel, Caroline Angerer, Mareke Brüning, Katja Petry, Andrzej Dzionek, Astrid A van der Veldt, Dirk J van Grünhagen, Johanna E M Werner, Johannes J Bonenkamp, John B A G Haanen, Marye J Boers-Sonderen, Rutger H T Koornstra, Martijn F Boomsma, Erik H J Aarntzen, Martin Gotthardt, James Nagarajah, Theo J M de Witte, Carl G Figdor, Johannes H W de Wilt, Johannes C Textor, Jan Willem B de Groot, Winald R Gerritsen, Ingrid Jolanda M De Vries
Adjuvant dendritic cell therapy in stage IIIB/C melanoma: the MIND-DC randomized phase III trial. Nature communications 15 (1) (2024)
Johanna Bödder, Leanne M Kok, Jonathan A Fauerbach, Georgina Flórez-Grau, Ingrid Jolanda M De Vries
Tailored PGE2 Immunomodulation of moDCs by Nano-Encapsulated EP2/EP4 Antagonists. International journal of molecular sciences 24 (2) (2023)
Johanna Bödder, Leanne M Kok, Jonathan A Fauerbach, Georgina Flórez-Grau, Ingrid Jolanda M De Vries
Tailored PGE2 Immunomodulation of moDCs by Nano-Encapsulated EP2/EP4 Antagonists. International journal of molecular sciences 24 (2) (2023)
Jeroen H A Creemers, Ankur Ankan, Kit C B Roes, Gijs Schröder, Niven Mehra, Carl G Figdor, Ingrid Jolanda M De Vries, Johannes C Textor
In silico cancer immunotherapy trials uncover the consequences of therapy-specific response patterns for clinical trial design and outcome. Nature communications 14 (1) (2023)
Jeroen H A Creemers, Ankur Ankan, Kit C B Roes, Gijs Schröder, Niven Mehra, Carl G Figdor, Ingrid Jolanda M De Vries, Johannes C Textor
In silico cancer immunotherapy trials uncover the consequences of therapy-specific response patterns for clinical trial design and outcome. Nature communications 14 (1) (2023)
Jeroen H A Creemers, Ankur Ankan, Kit C B Roes, Gijs Schröder, Niven Mehra, Carl G Figdor, Ingrid Jolanda M De Vries, Johannes C Textor
In silico cancer immunotherapy trials uncover the consequences of therapy-specific response patterns for clinical trial design and outcome. Nature communications 14 (1) (2023)
Jeroen H A Creemers, Ankur Ankan, Kit C B Roes, Gijs Schröder, Niven Mehra, Carl G Figdor, Ingrid Jolanda M De Vries, Johannes C Textor
In silico cancer immunotherapy trials uncover the consequences of therapy-specific response patterns for clinical trial design and outcome. Nature communications 14 (1) (2023)
Jeroen H A Creemers, Ankur Ankan, Kit C B Roes, Gijs Schröder, Niven Mehra, Carl G Figdor, Ingrid Jolanda M De Vries, Johannes C Textor
In silico cancer immunotherapy trials uncover the consequences of therapy-specific response patterns for clinical trial design and outcome. Nature communications 14 (1) (2023)
Johanna Bödder, Leanne M Kok, Jonathan A Fauerbach, Georgina Flórez-Grau, Ingrid Jolanda M De Vries
Tailored PGE2 Immunomodulation of moDCs by Nano-Encapsulated EP2/EP4 Antagonists. International journal of molecular sciences 24 (2) (2023)
Johanna Bödder, Leanne M Kok, Jonathan A Fauerbach, Georgina Flórez-Grau, Ingrid Jolanda M De Vries
Tailored PGE2 Immunomodulation of moDCs by Nano-Encapsulated EP2/EP4 Antagonists. International journal of molecular sciences 24 (2) (2023)
Mark A J Gorris, Lieke L van der Woude, Leonie I Kroeze, Kalijn Fredrike Bol, Kiek Verrijp, Avital L Amir, Jelena Meek, Johannes C Textor, Carl G Figdor, Ingrid Jolanda M De Vries
Paired primary and metastatic lesions of patients with ipilimumab-treated melanoma: high variation in lymphocyte infiltration and HLA-ABC expression whereas tumor mutational load is similar and correlates with clinical outcome. Journal for immunotherapy of cancer 10 (5) (2022)
Lieke L van der Woude, Mark A J Gorris, Inge M N Wortel, Jeroen H A Creemers, Kiek Verrijp, Kim Monkhorst, Katrien Grünberg, Michel M van den Heuvel, Johannes C Textor, Carl G Figdor, Berber Piet, Willemijn S M E Theelen, Ingrid Jolanda M De Vries
Tumor microenvironment shows an immunological abscopal effect in patients with NSCLC treated with pembrolizumab-radiotherapy combination. Journal for immunotherapy of cancer 10 (10) (2022)
Camille Le Gall, Anna Cammarata, Lukas de Haas, Iván Ramos-Tomillero, Jorge Cuenca-Escalona, Kayleigh Schouren, Zacharias Wijfjes, Anouk M D Becker, Johanna Bödder, Yusuf Dölen, Ingrid Jolanda M De Vries, Carl G Figdor, Georgina Flórez-Grau, Martijn Verdoes
Efficient targeting of NY-ESO-1 tumor antigen to human cDC1s by lymphotactin results in cross-presentation and antigen-specific T cell expansion. Journal for immunotherapy of cancer 10 (4) (2022)
Jeroen H A Creemers, Willem Joost Lesterhuis, Niven Mehra, Winald R Gerritsen, Carl G Figdor, Ingrid Jolanda M De Vries, Johannes C Textor
A tipping point in cancer-immune dynamics leads to divergent immunotherapy responses and hampers biomarker discovery. Journal for immunotherapy of cancer 9 (5) (2022)
Jamie I Scott, Lorena Mendive-Tapia, Doireann Gordon, Nicole D Barth, Emily J Thompson, Zhiming Cheng, David Taggart, Takanori Kitamura, Alberto Bravo-Blas, Edward W Roberts, Jordi Juárez-Jiménez, Julien Michel, Berber Piet, Ingrid Jolanda M De Vries, Martijn Verdoes, John C Dawson, Neil O Carragher, Richard A O' Connor, Ahsan R Akram, Margaret Frame, Margaret C Frame, Marc Vendrell
A fluorogenic probe for granzyme B enables in-biopsy evaluation and screening of response to anticancer immunotherapies. Nature communications 13 (1) (2022)
Maria Camilla Operti, Alexander Bernhardt, Jeanette Pots, Vladimir Sincari, Elie Zer Ja Ger, Silko Grimm, Andrea Engel, Anne Benedikt, Martin Hrubý, Ingrid Jolanda M De Vries, Carl G Figdor, Oya Tagit
Translating the Manufacture of Immunotherapeutic PLGA Nanoparticles from Lab to Industrial Scale: Process Transfer and In Vitro Testing. Pharmaceutics 14 (8) (2022)
Sandra van Wilpe, Victoria Wosika, Laura Ciarloni, Sahar Hosseinian Ehrensberger, Rachel Jeitziner, Paolo Angelino, Tjitske Duiveman-de Boer, Rutger H T Koornstra, Ingrid Jolanda M De Vries, Winald R Gerritsen, Jack Schalken, Niven Mehra
Whole Blood Transcriptome Profiling Identifies DNA Replication and Cell Cycle Regulation as Early Marker of Response to Anti-PD-1 in Patients with Urothelial Cancer. Cancers 13 (18) (2021)
Asima Abidi, Mark A J Gorris, Evan Brennan, Marjolijn C J Jongmans, Dilys D Weijers, Roland P Kuiper, Richarda M de Voer, Nicoline Hoogerbrugge, Ghaith Bakdash, Ingrid Jolanda M De Vries
Challenges of Neoantigen Targeting in Lynch Syndrome and Constitutional Mismatch Repair Deficiency Syndrome. Cancers 13 (10) (2021)
Massis Krekorian, Kimberley R G Cortenbach, Milou Boswinkel, Annemarie Kip, Gerben M Franssen, Andor Veltien, Tom W J Scheenen, René Raavé, Nicolaas Koen van Riessen, Mangala Srinivas, Ingrid Jolanda M De Vries, Carl G Figdor, Erik H J G Aarntzen, Sandra Heskamp
In Vivo PET Imaging of Monocytes Labeled with [89Zr]Zr-PLGA-NH2 Nanoparticles in Tumor and Staphylococcus aureus Infection Models. Cancers 13 (20) (2021)
Sandra van Wilpe, Sofie H Tolmeijer, Rutger H T Koornstra, Ingrid Jolanda M De Vries, Winald R Gerritsen, Marjolijn J L Ligtenberg, Niven Mehra
Homologous Recombination Repair Deficiency and Implications for Tumor Immunogenicity. Cancers 13 (9) (2021)
Steve Boudewijns, Martine Bloemendal, Nienke de Haas, Harm Westdorp, Kalijn Fredrike Bol, Ghaith Bakdash, Erik H J G Aarntzen, Willem Joost Lesterhuis, Mark A J Gorris, Alexandra Croockewit, Lieke L van der Woude, Michelle M van Rossum, Marieke Welzen, Anna de Goede, Stanleyson V Hato, Winette T A van der Graaf, Cornelis J A Punt, Rutger H T Koornstra, Winald R Gerritsen, Carl G Figdor, Ingrid Jolanda M De Vries
Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial. Cancer immunology, immunotherapy : CII 69 (3) (2020)
S Di Blasio, G F van Wigcheren, Anouk M D Becker, Anne van Duffelen, Mark A J Gorris, K Verrijp, Irene Stefanini, Gert-Jan Bakker, M Bloemendal, A Halilovic, A Vasaturo, G Bakdash, S V Hato, Johannes H W de Wilt, J Schalkwijk, Ingrid Jolanda M De Vries, Johannes C Textor, E H van den Bogaard, Marcella Tazzari, Carl G Figdor
The tumour microenvironment shapes dendritic cell plasticity in a human organotypic melanoma culture. Nature communications 11 (1) (2020)
Nienke de Haas, Coco de Koning, Stefania di Blasio, Georgina Flórez-Grau, Ingrid Jolanda M De Vries, Stanleyson V Hato
STAT Family Protein Expression and Phosphorylation State during moDC Development Is Altered by Platinum-Based Chemotherapeutics. Journal of immunology research 2019 (2019)
Edyta Swider, Alexander H J Staal, N Koen van Riessen, Linsey Jacobs, Paul B White, Remco Fokkink, Geert-Jan Janssen, Eric van Dinther, Carl G Figdor, Ingrid Jolanda M De Vries, Olga Koshkina, Mangala Srinivas
Design of triphasic poly(lactic- co -glycolic acid) nanoparticles containing a perfluorocarbon phase for biomedical applications. RSC advances 8 (12) (2018)
Martine Bloemendal, Mark J A Rietveld, W W van Willigen, W R Gerritsen, Carl G Figdor, Johannes J Bonenkamp, Harm Westdorp, Steve Boudewijns, Rutger H T Koornstra, Eddy M M Adang, Ghaith Bakdash, Petronella B Ottevanger, Ingrid Jolanda M De Vries, Kalijn Fredrike Bol
Health-related quality of life analysis in stage III melanoma patients treated with adjuvant dendritic cell therapy. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 21 (6) (2018)
Mark A J Gorris, Altuna Halilovic, Katrin Rabold, Anne van Duffelen, Iresha N Wickramasinghe, Dagmar Verweij, Inge M N Wortel, Johannes C Textor, Ingrid Jolanda M De Vries, Carl G Figdor
Eight-Color Multiplex Immunohistochemistry for Simultaneous Detection of Multiple Immune Checkpoint Molecules within the Tumor Microenvironment. Journal of immunology (Baltimore, Md. : 1950) 200 (1) (2017)

Ingrid Jolanda M De Vries.css-eqlu8i{font-size:small;padding-left:4px;} (Ingrid Jolanda M de Vries, I Jolanda de Vries, I Jolanda M de Vries, I J M de Vries)

Publication Activity (10 Years)

Top Topics

Top Venues

Ingrid Jolanda M De Vries (Ingrid Jolanda M de Vries, I Jolanda de Vries, I Jolanda M de Vries, I J M de Vries)